THE ASSESMENT OF SIGNIFICANCE OF THE RETROPERITONEAL LYMPH NODE DISSECTION IN PROXIMITY OF METASTATIC TUMOR WITH MAIN VESSELS IN PATIENTS WITH GERM CELL TESTICULAR TUMORS
https://doi.org/10.24884/0042-4625-2013-172-1-094-098
Abstract
The therapeutic approach should be defined more exactly in proximity of residual retroperitoneal metastases of germ cell testicular tumor and main vessels (left after chemotherapy). The data of 29 (24%) patients were analyzed over a period of time since 2003 till 2011. The general survival was 82% in the group without lymph node dissection (17 patients) in median observation of 27.5 months. The proximity with main vessels was registered in half of the cases in the group of operated patients (12 people), a single vascular reconstruction was required. The general survival was 97% in median observation for 35 months. The involvement of main vessels of retroperitoneal space significantly complicated the retroperitoneal lymph node dissection, but didn’t have negative prognostic value.
About the Authors
O. S. Tereshin
Chelyabinsk regional clinical oncologic dispensary
Russian Federation
Russian Federation
S. P. Zotov
Chelyabinsk regional clinical oncologic dispensary
Russian Federation
Russian Federation
A. V. Vazhenin
Chelyabinsk regional clinical oncologic dispensary
Russian Federation
Russian Federation
A. O. Mamonova
Chelyabinsk regional clinical oncologic dispensary
Russian Federation
Russian Federation
References
1. Магер В. О., Петкау В. В., Щеглова В. П. Непосредственные и отдаленные результаты забрюшинной лимфаденэктомии в лечении герминогенных опухолей яичка // Уральск. мед. журн. 2012. № 3, С. 72–74.
2. Матвеев В. Б., Волкова М. И., Черняев В. А. и др. Забрюшинная лимфаденэктомия при диссеминированных несеминомных герминогенных опухолях яичка после химиотерапии с сохранением положительных опухолевых маркёров // Урология. 2010. № 3, С. 41–47.
3. Тюляндин С. А., Буланов А. А., Гарин А. М. и др. Лечение больных с диссеминированными герминогенными опухолями // Вопр. онкол. 2002. № 4. С. 576–582.
4. Фигурин К. М. Постхимиотерапевтические забрюшинные лимфаденэктомии // Практ. онкол. 2006. № 1. С. 39–43.
5. Albers P., Albrecht W., Algaba F. et al. Guidelines on testicular cancer // Eur. Urol. 2005. Vol. 48. P. 885–894.
6. Beck S. D., Foster R. S., Bihrle R. et al. Is full bilateral retroperitoneal lymph node dissection always necessary for post chemotherapy residual tumor? // Cancer. 2007. Vol. 110. P. 1235–1240.
7. Heidenreich A., Thüer D., Polyakov S. Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumours of the Testis // Eur. Urol. 2008. Vol. 53. P. 260–272.
8. Mosharafa A. A., Foster R. S., Koch M. O. et al. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer // J. Urol. 2004. Vol. 171. P. 1839–1841.
9. Schmoll H.J, Souchon R., Krege S. et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) // Ann. Oncol. 2004. Vol. 15. P. 1377–1399.
10. Tavolini I. M., Norcen M., Oliva G. et al. Caval involvement in advanced-stage non-seminoma testicular tumors: surgical strategy and long-term results // Arch. Ital. Urol. Androl. 2002. Vol. 74. P. 69–76.
11. Winter C., Pfister D., Busch J. et al. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group // Eur. Urol. 2012. Vol. 61. P. 403–409.
Review
For citations:
Tereshin O.S., Zotov S.P., Vazhenin A.V., Mamonova A.O. THE ASSESMENT OF SIGNIFICANCE OF THE RETROPERITONEAL LYMPH NODE DISSECTION IN PROXIMITY OF METASTATIC TUMOR WITH MAIN VESSELS IN PATIENTS WITH GERM CELL TESTICULAR TUMORS. Grekov's Bulletin of Surgery. 2013;172(1):094-098. (In Russ.) https://doi.org/10.24884/0042-4625-2013-172-1-094-098
Views:
377
Email this article 